CAS 1887095-82-0

Rapalink-1

CAS : 1887095-82-0

Formule : C₉₁H₁₃₈N₁₂O₂₄

Degré de pureté : 95%

Masse moléculaire : 1784.1354

Ref: IN-DA01N1CT

Rapalink-1

CAS : 1887095-82-0

Rapalink-1 is an mTOR inhibitor that inhibits the mTORC1-4E-BP1 pathway in mice.

Formule : C₉₁H₁₃₈N₁₂O₂₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 1784.14

Ref: TM-TP2288

Rapalink-1

CAS : 1887095-82-0

Rapalink-1 is a gene therapy drug that has been shown to be effective against resistant mutants of malignant brain tumors. Rapalink-1 is a protein that has been engineered to bind to mesenchymal markers and inhibit the progression of cancer cells. This protein also has the ability to induce autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients. Rapalink-1 inhibits tumor growth by triggering autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients. Rapalink-1 is an autophagy inducer that binds to mesenchymal markers on cancer cells and inhibits the progression of cancer cells. It also has the ability to induce autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients.

Formule : C₉₁H₁₃₈N₁₂O₂₄

Degré de pureté : Min. 95%

Masse moléculaire : 1,784.1 g/mol

Ref: 3D-MAD09582